Di Leva et al. reported that cell cycle regulatory proteins such as CDK6 and CCND2 were established as targets of miR-191 in thyroid carcinoma and aggressive breast cancer and showed that miR-191-mediated down-regulation of CDK6 led to reduced cell proliferation [16, 20]. The gene discussed is CDK6; the disease is thyroid gland carcinoma.